Hexestrol dibromoacetate
Latest Information Update: 14 Nov 2000
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 14 Nov 2000 No-Development-Reported for Breast cancer in Japan (Unknown route)